Research Topic · Peer-Reviewed

Treatments

Treatments, in the context of coronavirus disease, comprise the pharmacological and supportive interventions used to reduce symptoms, limit disease progression, and lower mortality in infected patients. They span several mechanistic categories: direct-acting antivirals that interfere with viral replication; immunomo…

Curated from this journal's research 📚 6 peer-reviewed articles cited Cited 30× across the literature 🔖 ISSN 2692-1537 🗓 Reviewed July 2026

Overview

Treatments, in the context of coronavirus disease, comprise the pharmacological and supportive interventions used to reduce symptoms, limit disease progression, and lower mortality in infected patients. They span several mechanistic categories: direct-acting antivirals that interfere with viral replication; immunomodulatory agents, including interferons and anti-inflammatory drugs, that temper the dysregulated host response driving severe illness; repurposed compounds evaluated in clinical trials; and supportive and rehabilitative care for critically ill patients, such as those recovering in intensive-care settings. Research in this area assesses candidate therapies through controlled studies measuring clinical improvement and survival, recognizing that early observational enthusiasm for some agents has required rigorous testing to confirm or refute benefit. The trajectory of COVID-19 therapeutics illustrates the broader principle that new drugs, treatments, and devices must undergo clinical evaluation before adoption, because efficacy and safety cannot be assumed from mechanism alone. Investigators also explore adjunctive and complementary approaches and the role of host-directed strategies. Selecting appropriate treatment depends on disease severity, timing within the illness course, and patient risk factors. As an evolving field, coronavirus treatment integrates virology, immunology, pharmacology, and clinical trial methodology to build an evidence base that distinguishes interventions that genuinely improve outcomes from those that do not.

Research published in this journal

6 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 6 articles above have been cited 30 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Treatments, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Coronaviruses (ISSN 2692-1537).

Journal editorial board
Dr. Omeed Memar · USA Dr. SUDIPTI GUPTA · United States Dr. Jose Luis Turabian · Spain

This page summarises published research for orientation; it is not medical or professional advice.